Clinical Trials / Research Studies
Clinical Trials / Research Studies

Asthma Study for Children and Teens 6 to 17 Years Old

Why are we doing this research?

Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn if an asthma medication, Dupilumab, given along with standard asthma care, helps to make children less likely to have asthma attacks.

Who can participate?

Children and teens 6 to 17 years old with asthma who:

  • Have had 2 or more asthma attacks in the last year and
  •  Are taking a daily inhaled medication

Conditions

  • Asthma
  • Chest and Lungs - Respiratory Tract

What will happen in the study?

This study includes 33 study visits at Cincinnati Children’s over a 16-month period and up to 3 visits when your child has a cold.

Here are some of the things that will happen in this study:

We will ask you questions about your child’s health.

Your child will:

  • Complete breathing tests
  • Have an allergy skin test
  • Submit blood, urine and nasal samples
  • Be randomized to either receive the study drug, Dupilumab, or a placebo (inactive) shot

The study team will ask you to call if your child starts to show signs of a cold and bring them in for a “cold” visit. The purpose of these visits is to collect samples soon after his/her cold starts.

Parents or guardians interested in having their child participate will be given a consent form that thoroughly explains all of the details of the study. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered.

What are the good things that can happen from this research?

Your child may directly benefit by receiving asthma care from an asthma specialist. You will receive information about your child’s breathing and allergen tests, as well as information about taking care of your child’s asthma.

Your child’s asthma and rhinitis may or may not improve while in this study, but he/she will be followed closely during the study.

Overall, the information we learn from this study may lead to study doctors having a better understanding of whether dupilumab helps children to have fewer asthma attacks.

What are the bad things that can happen from this research?

Possible risks and discomforts will be discussed with parents or guardians interested in learning more about the study.

Will you/your child be paid to be in this research study?

Families will receive up to $1,850 over approximately 16 months (33 visits) for time and travel.

Contact

Contact Us.CAUSE Study Team
513-356-6102
CAUSEScheduling@cchmc.org
Asthma Research Center
Cincinnati Children’s
3333 Burnet Ave.
Cincinnati, OH 45229-3039

Study Doctor

Contact Us.Gurjit K. Hershey, MD, PhD
Asthma Research Center
Cincinnati Children’s